Global Anca Vasculitis Drug Market Research Report 2023

Report ID: 1978278 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Anca Vasculitis Drug Market Overview
    1.1 Product Overview and Scope of Anca Vasculitis Drug
    1.2 Anca Vasculitis Drug Segment by Type
        1.2.1 Global Anca Vasculitis Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Belimumab
        1.2.3 CCX-1378
        1.2.4 CCX-168
        1.2.5 Dalazatide
        1.2.6 Others
    1.3 Anca Vasculitis Drug Segment by Application
        1.3.1 Global Anca Vasculitis Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Anca Vasculitis Drug Market Size Estimates and Forecasts
        1.4.1 Global Anca Vasculitis Drug Revenue 2017-2028
        1.4.2 Global Anca Vasculitis Drug Sales 2017-2028
        1.4.3 Anca Vasculitis Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Anca Vasculitis Drug Market Competition by Manufacturers
    2.1 Global Anca Vasculitis Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Anca Vasculitis Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Anca Vasculitis Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Anca Vasculitis Drug Manufacturing Sites, Area Served, Product Type
    2.5 Anca Vasculitis Drug Market Competitive Situation and Trends
        2.5.1 Anca Vasculitis Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Anca Vasculitis Drug Players Market Share by Revenue
        2.5.3 Global Anca Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anca Vasculitis Drug Retrospective Market Scenario by Region
    3.1 Global Anca Vasculitis Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Anca Vasculitis Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Anca Vasculitis Drug Market Facts & Figures by Country
        3.3.1 North America Anca Vasculitis Drug Sales by Country
        3.3.2 North America Anca Vasculitis Drug Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Anca Vasculitis Drug Market Facts & Figures by Country
        3.4.1 Europe Anca Vasculitis Drug Sales by Country
        3.4.2 Europe Anca Vasculitis Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Anca Vasculitis Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Anca Vasculitis Drug Sales by Region
        3.5.2 Asia Pacific Anca Vasculitis Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Anca Vasculitis Drug Market Facts & Figures by Country
        3.6.1 Latin America Anca Vasculitis Drug Sales by Country
        3.6.2 Latin America Anca Vasculitis Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Anca Vasculitis Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Anca Vasculitis Drug Sales by Country
        3.7.2 Middle East and Africa Anca Vasculitis Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Anca Vasculitis Drug Historic Market Analysis by Type
    4.1 Global Anca Vasculitis Drug Sales Market Share by Type (2017-2022)
    4.2 Global Anca Vasculitis Drug Revenue Market Share by Type (2017-2022)
    4.3 Global Anca Vasculitis Drug Price by Type (2017-2022)
5 Global Anca Vasculitis Drug Historic Market Analysis by Application
    5.1 Global Anca Vasculitis Drug Sales Market Share by Application (2017-2022)
    5.2 Global Anca Vasculitis Drug Revenue Market Share by Application (2017-2022)
    5.3 Global Anca Vasculitis Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 ChemoCentryx, Inc.
        6.1.1 ChemoCentryx, Inc. Corporation Information
        6.1.2 ChemoCentryx, Inc. Description and Business Overview
        6.1.3 ChemoCentryx, Inc. Anca Vasculitis Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 ChemoCentryx, Inc. Anca Vasculitis Drug Product Portfolio
        6.1.5 ChemoCentryx, Inc. Recent Developments/Updates
    6.2 GlaxoSmithKline plc
        6.2.1 GlaxoSmithKline plc Corporation Information
        6.2.2 GlaxoSmithKline plc Description and Business Overview
        6.2.3 GlaxoSmithKline plc Anca Vasculitis Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 GlaxoSmithKline plc Anca Vasculitis Drug Product Portfolio
        6.2.5 GlaxoSmithKline plc Recent Developments/Updates
    6.3 Kineta, Inc.
        6.3.1 Kineta, Inc. Corporation Information
        6.3.2 Kineta, Inc. Description and Business Overview
        6.3.3 Kineta, Inc. Anca Vasculitis Drug Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Kineta, Inc. Anca Vasculitis Drug Product Portfolio
        6.3.5 Kineta, Inc. Recent Developments/Updates
7 Anca Vasculitis Drug Manufacturing Cost Analysis
    7.1 Anca Vasculitis Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Anca Vasculitis Drug
    7.4 Anca Vasculitis Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Anca Vasculitis Drug Distributors List
    8.3 Anca Vasculitis Drug Customers
9 Anca Vasculitis Drug Market Dynamics
    9.1 Anca Vasculitis Drug Industry Trends
    9.2 Anca Vasculitis Drug Market Drivers
    9.3 Anca Vasculitis Drug Market Challenges
    9.4 Anca Vasculitis Drug Market Restraints
10 Global Market Forecast
    10.1 Anca Vasculitis Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Anca Vasculitis Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Anca Vasculitis Drug by Type (2023-2028)
    10.2 Anca Vasculitis Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Anca Vasculitis Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Anca Vasculitis Drug by Application (2023-2028)
    10.3 Anca Vasculitis Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Anca Vasculitis Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Anca Vasculitis Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Anca Vasculitis Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Anca Vasculitis Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Anca Vasculitis Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Anca Vasculitis Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Anca Vasculitis Drug Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Anca Vasculitis Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Anca Vasculitis Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Anca Vasculitis Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Anca Vasculitis Drug Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Anca Vasculitis Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers Anca Vasculitis Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Anca Vasculitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anca Vasculitis Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Anca Vasculitis Drug Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Anca Vasculitis Drug Sales Market Share by Region (2017-2022)
    Table 17. Global Anca Vasculitis Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Anca Vasculitis Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America Anca Vasculitis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Anca Vasculitis Drug Sales Market Share by Country (2017-2022)
    Table 21. North America Anca Vasculitis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Anca Vasculitis Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe Anca Vasculitis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Anca Vasculitis Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe Anca Vasculitis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Anca Vasculitis Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Anca Vasculitis Drug Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Anca Vasculitis Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Anca Vasculitis Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Anca Vasculitis Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Anca Vasculitis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Anca Vasculitis Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America Anca Vasculitis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Anca Vasculitis Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Anca Vasculitis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Anca Vasculitis Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Anca Vasculitis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Anca Vasculitis Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global Anca Vasculitis Drug Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Anca Vasculitis Drug Sales Market Share by Type (2017-2022)
    Table 41. Global Anca Vasculitis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Anca Vasculitis Drug Revenue Share by Type (2017-2022)
    Table 43. Global Anca Vasculitis Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Anca Vasculitis Drug Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Anca Vasculitis Drug Sales Market Share by Application (2017-2022)
    Table 46. Global Anca Vasculitis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Anca Vasculitis Drug Revenue Share by Application (2017-2022)
    Table 48. Global Anca Vasculitis Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 49. ChemoCentryx, Inc. Corporation Information
    Table 50. ChemoCentryx, Inc. Description and Business Overview
    Table 51. ChemoCentryx, Inc. Anca Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. ChemoCentryx, Inc. Anca Vasculitis Drug Product
    Table 53. ChemoCentryx, Inc. Recent Developments/Updates
    Table 54. GlaxoSmithKline plc Corporation Information
    Table 55. GlaxoSmithKline plc Description and Business Overview
    Table 56. GlaxoSmithKline plc Anca Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. GlaxoSmithKline plc Anca Vasculitis Drug Product
    Table 58. GlaxoSmithKline plc Recent Developments/Updates
    Table 59. Kineta, Inc. Corporation Information
    Table 60. Kineta, Inc. Description and Business Overview
    Table 61. Kineta, Inc. Anca Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Kineta, Inc. Anca Vasculitis Drug Product
    Table 63. Kineta, Inc. Recent Developments/Updates
    Table 64. Production Base and Market Concentration Rate of Raw Material
    Table 65. Key Suppliers of Raw Materials
    Table 66. Anca Vasculitis Drug Distributors List
    Table 67. Anca Vasculitis Drug Customers List
    Table 68. Anca Vasculitis Drug Market Trends
    Table 69. Anca Vasculitis Drug Market Drivers
    Table 70. Anca Vasculitis Drug Market Challenges
    Table 71. Anca Vasculitis Drug Market Restraints
    Table 72. Global Anca Vasculitis Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 73. Global Anca Vasculitis Drug Sales Market Share Forecast by Type (2023-2028)
    Table 74. Global Anca Vasculitis Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 75. Global Anca Vasculitis Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 76. Global Anca Vasculitis Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 77. Global Anca Vasculitis Drug Sales Market Share Forecast by Application (2023-2028)
    Table 78. Global Anca Vasculitis Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 79. Global Anca Vasculitis Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 80. Global Anca Vasculitis Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 81. Global Anca Vasculitis Drug Sales Market Share Forecast by Region (2023-2028)
    Table 82. Global Anca Vasculitis Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 83. Global Anca Vasculitis Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anca Vasculitis Drug
    Figure 2. Global Anca Vasculitis Drug Market Share by Type in 2021 & 2028
    Figure 3. Belimumab Product Picture
    Figure 4. CCX-1378 Product Picture
    Figure 5. CCX-168 Product Picture
    Figure 6. Dalazatide Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Anca Vasculitis Drug Market Share by Application in 2021 & 2028
    Figure 9. Hospital
    Figure 10. Clinic
    Figure 11. Others
    Figure 12. Global Anca Vasculitis Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Anca Vasculitis Drug Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Anca Vasculitis Drug Sales (2017-2028) & (K Pcs)
    Figure 15. Anca Vasculitis Drug Sales Share by Manufacturers in 2021
    Figure 16. Global Anca Vasculitis Drug Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Anca Vasculitis Drug Players: Market Share by Revenue in 2021
    Figure 18. Anca Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Anca Vasculitis Drug Sales Market Share by Region (2017-2022)
    Figure 20. Global Anca Vasculitis Drug Sales Market Share by Region in 2021
    Figure 21. Global Anca Vasculitis Drug Revenue Market Share by Region (2017-2022)
    Figure 22. Global Anca Vasculitis Drug Revenue Market Share by Region in 2021
    Figure 23. U.S. Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Taiwan Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Philippines Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Vietnam Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Turkey Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Saudi Arabia Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. UAE Anca Vasculitis Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Sales Market Share of Anca Vasculitis Drug by Type (2017-2022)
    Figure 48. Manufacturing Cost Structure of Anca Vasculitis Drug
    Figure 49. Manufacturing Process Analysis of Anca Vasculitis Drug
    Figure 50. Anca Vasculitis Drug Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ChemoCentryx, Inc.
GlaxoSmithKline plc
Kineta, Inc.
Frequently Asked Questions
Anca Vasculitis Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anca Vasculitis Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anca Vasculitis Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Waterproof Panel

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More